Análisis Argos
THC
THCBarata · ojo al riesgo
Tenet Healthcare Corporation · Healthcare
US$ 203.72
precio al 2026-07-04
Valor justo Argos*
US$ 211
vs. su valor justo
▲+4%
Score Argos
60/100
Barata · ojo al riesgo
LA RESPUESTA
El mercado la precia para que crezca 4% al año — menos de lo que viene demostrando (8.5%). Un negocio de calidad castigado por expectativas pesimistas: por eso está entre las llamadas de Argos. Ojo: tiene señales de riesgo en sus números — es barata con asterisco.
Recompensas
✓Cotiza por debajo de su valor justo: el mercado le pide menos crecimiento del que viene demostrando.
✓Retorno sobre el capital alto (20%).
Riesgos
!Balance frágil: la deuda pesa sobre el negocio.
!Crecimiento estancado o en baja.
VALOR4/6FUTURO1/6PASADO5/6SALUD2/6DIVIDENDO5/6
El Iris de calidad
VALOR4/6FUTURO1/6PASADO5/6SALUD2/6DIVIDENDO5/6
ValorCotiza por debajo de su valor justo
FuturoIngresos estancados o cayendo
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos60de 100Barata · ojo al riesgo
Ingresos▲3%
US$ 21.3 B
Margen operativo▼44%
16.1%
Flujo de caja libre▲126%
US$ 2.5 B
Deuda neta
US$ 10.3 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 17.5B
P/E12.5x
EV/EBITDA6.5x
FCF yield14.4%
ROIC20%
Margen operativo16.1%
Crecim. ingresos+3.1%/año
Piotroski F6/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 23 jun
Tenet Healthcare (THC) Ascends While Market Falls: Some Facts to Note
In the most recent trading session, Tenet Healthcare (THC) closed at $180.88, indicating a +1.19% shift from the previous trading day.
businesswire.com · 22 jun
Tenet to Report Its Second Quarter 2026 Results on July 24
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (NYSE: THC) will release its second quarter 2026 results before the market opens on Friday, July 24, 2026, to be followed by a conference call at 10:30 a.m. CT (11:30 a.m. Eastern Time).A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors.About Tenet HealthcareTenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company.
zacks.com · 18 jun
Tenet (THC) Upgraded to Buy: Here's Why
Tenet (THC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
zacks.com · 18 jun
Tenet Healthcare Corporation (THC) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Tenet (THC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
zacks.com · 15 jun
Tenet Healthcare (THC) Laps the Stock Market: Here's Why
Tenet Healthcare (THC) closed the most recent trading day at $179.11, moving +2.55% from the previous trading session.
zacks.com · 15 jun
Why Tenet Healthcare (THC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com · 12 jun
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com · 11 jun
3 Reasons Why Growth Investors Shouldn't Overlook Tenet (THC)
Tenet (THC) possesses solid growth attributes, which could help it handily outperform the market.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.